Shizhang Ling

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Cell Cycle Arrest

Chemotherapy Induced

Top Venues

The Journal of pharmacy and pharmacology

Cancer research

Analytical cellular pathology (Amsterdam)

This page only lists publications with an associated author ORCID identifier.

Publications

Wenyi Xi, Chenhui Zhao, Zeyu Wu, Tongtong Ye, Rui Zhao, Xiaochun Jiang, Shizhang Ling
Brusatol's anticancer activity and its molecular mechanism: a research update. The Journal of pharmacy and pharmacology (2024)
Wenyi Xi, Chenhui Zhao, Zeyu Wu, Tongtong Ye, Rui Zhao, Xiaochun Jiang, Shizhang Ling
Brusatol's anticancer activity and its molecular mechanism: a research update. The Journal of pharmacy and pharmacology 76 (7) (2024)
Changshu Li, Ji Liu, Yuanyuan Lyu, Shizhang Ling, Yonghong Luo
METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/ β -Catenin Axis. Analytical cellular pathology (Amsterdam) 2023 (2023)
Joseph O Humtsoe, Hyun-Su Kim, Brandon Leonard, Shizhang Ling, Bhumsuk Keam, Luigi Marchionni, Bahman Afsari, Michael Considine, Alexander V Favorov, Elana J Fertig, Hyunseok Kang, Patrick K Ha
Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma. Cancer research 81 (4) (2021)